Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9051339 | 1.00 | KDM4E (0.35) | KDM4EALDH1A1LMNAMAPTSMN1; SMN2 | |
| SCHEMBL12852025 | 1.00 | KDM4E (0.35) | KDM4EALDH1A1LMNAMAPTSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL2994325 | 0.98 | KDM4E (0.34) | KDM4EALDH1A1LMNAMAPTSMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL2994327 | 0.98 | KDM4E (0.34) | KDM4EALDH1A1LMNAMAPTSMN1; SMN2 | |
| SCHEMBL2151480 | 0.87 | — | — | |
| SCHEMBL8692043 | 0.86 | KDM4E (0.30) | KDM4E | |
| SCHEMBL14107832 | 0.80 | — | — | |
| SCHEMBL430692 | 0.80 | GNAI3 (0.32) | — | |
| SCHEMBL25910486 | 0.79 | KDM4E (0.37) | KDM4EALDH1A1MAPTSMN1; SMN2OPRM1 | |
| SCHEMBL24750369 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4317128-B1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | MILLIKEN & CO (US) | 2025-07-23 | — | — | EP | disclosed |
| US-12358864-B2 | Trisamide compounds and compositions comprising the same | MILLIKEN & COMPANY (US) | 2025-07-15 | — | — | US | disclosed |
| CN-117756661-A | Triamide compound and composition comprising same | 美利肯公司 | 2024-03-26 | — | — | CN | disclosed |
| EP-4317128-A2 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | Milliken & Company (US) | 2024-02-07 | — | — | EP | disclosed |
| EP-4073029-B1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | MILLIKEN & CO (US) | 2024-01-31 | — | — | EP | disclosed |
| CN-115066413-B | Triamide compound and composition comprising same | 美利肯公司 | 2024-01-09 | — | — | CN | disclosed |
| US-20230331660-A1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | MILLIKEN & COMPANY | 2023-10-19 | — | — | US | disclosed |
| US-11724983-B2 | Trisamide compounds and compositions comprising the same | MILLIKEN & COMPANY (US) | 2023-08-15 | — | — | US | disclosed |
| US-20230159491-A1 | Antimicrobial Compounds and Methods | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2023-05-25 | — | — | US | disclosed |
| EP-4073029-A1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | Milliken & Company (US) | 2022-10-19 | — | — | EP | disclosed |
| EP-0962489-A2 | Crystalline polypropylene resin composition and amide compounds | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 1999-12-08 | — | — | EP | disclosed |
| US-5716998-A | PARTICLES COMPRISING POLYPROPYLENE RESIN AND DIAMIDE COMPOUND AS BETA-FORM NUCLEATING AGENT | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1998-02-10 | — | — | US | disclosed |
| CN-1169743-A | Propylene-ethylene copolymer composition and process for producing the same | CHISSO CORP (JP) | 1998-01-07 | — | — | CN | disclosed |
| EP-0790262-A1 | PROPYLENE-ETHYLENE COPOLYMER COMPOSITIONS AND PROCESS FOR THE PRODUCTION THEREOF | CHISSO CORPORATION (JP) | 1997-08-20 | — | — | EP | disclosed |
| EP-0790275-A1 | PREFOAMED PARTICLES OF POLYPROPYLENE RESIN AND PROCESS FOR PRODUCING THE SAME | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1997-08-20 | — | — | EP | disclosed |
| WO-1996037473-A1 | SUBSTITUTED 2,3-CYCLOALKENOPYRIDINES, PROCESS FOR PREPARING THE SAME, AGENTS CONTAINING THE SAME AND THEIR USE AS PESTICIDES AND FUNGICIDES | HOECHST SCHERING AGREVO GMBH (DE) | 1996-11-28 | — | — | WO | disclosed |
| US-5491188-A | ADDING DIAMIDE COMPOUNDS AS NUCLEATING AGENT TO PROPYLENE HOMO-, CO- AND TERPOLYMERS; FILTRATION MEMBRANES, PRINTING SHEETS | NEW JAPAN CHEMICAL CO., LTD. (JP) | 1996-02-13 | — | — | US | disclosed |
| CN-1098725-A | Based on porous stretched article of acrylic resin and preparation method thereof | NEW JAPAN CHEM CO LTD (JP) | 1995-02-15 | — | — | CN | disclosed |
| EP-0632095-A2 | Porous stretched article of polypropylene-based resin and process for its preparation | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 1995-01-04 | — | — | EP | disclosed |
| EP-0557721-A2 | Crystalline polypropylene resin composition and amide compounds | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 1993-09-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159491-A1 | Antimicrobial Compounds and Methods | MPO, NISCH, RPN2 | KDM4E 3027/4885ALDH1A1 3752/4885LMNA 3813/4885 |
| US-11724983-B2 | Trisamide compounds and compositions comprising the same | PTAR1, TIPRL, TCOF1 | KDM4E 2058/4885ALDH1A1 4713/4885LMNA 1411/4885 |
| US-20230331660-A1 | TRISAMIDE COMPOUNDS AND COMPOSITIONS COMPRISING THE SAME | PTAR1, TIPRL, TCOF1 | KDM4E 2058/4885ALDH1A1 4713/4885LMNA 1411/4885 |
| US-12358864-B2 | Trisamide compounds and compositions comprising the same | PTAR1, TIPRL, TCOF1 | KDM4E 2058/4885ALDH1A1 4713/4885LMNA 1411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.